A novel method to increase specificity of sleep-wake classifiers based on wrist-worn actigraphy.


Journal

Chronobiology international
ISSN: 1525-6073
Titre abrégé: Chronobiol Int
Pays: England
ID NLM: 8501362

Informations de publication

Date de publication:
05 2023
Historique:
medline: 13 6 2023
pubmed: 21 3 2023
entrez: 20 3 2023
Statut: ppublish

Résumé

The knowledge of the distribution of sleep and wake over a 24-h day is essential for a comprehensive image of sleep-wake rhythms. Current sleep-wake scoring algorithms for wrist-worn actigraphy suffer from low specificities, which leads to an underestimation of the time staying awake. The goal of this study (ClinicalTrials.gov Identifier: NCT03356938) was to develop a sleep-wake classifier with increased specificity. By artificially balancing the training dataset to contain as much wake as sleep epochs from day- and nighttime measurements from 12 subjects, we optimized the classification parameters to an optimal trade-off between sensitivity and specificity. The resulting sleep-wake classifier achieved high specificity of 80.4% and sensitivity of 88.6% on the balanced dataset containing 3079.9 h of actimeter data. In the validation on night sleep of separate adaptation recordings from 19 healthy subjects, the sleep-wake classifier achieved 89.4% sensitivity and 64.6% specificity and estimated accurately total sleep time and sleep efficiency with a mean difference of 12.16 min and 2.83%, respectively. This new, device-independent method allows to rid sleep-wake classifiers from their bias towards sleep detection and lay a foundation for more accurate assessments in everyday life, which could be applied to monitor patients with fragmented sleep-wake rhythms.

Identifiants

pubmed: 36938627
doi: 10.1080/07420528.2023.2188096
doi:

Banques de données

ClinicalTrials.gov
['NCT03356938']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

557-568

Auteurs

Franziska Ryser (F)

Rehabilitation Engineering Laboratory, ETH Zurich, Zurich, Switzerland.
Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Sleep and Health Zurich (SHZ), University of Zurich, Zurich, Switzerland.

Roger Gassert (R)

Rehabilitation Engineering Laboratory, ETH Zurich, Zurich, Switzerland.

Esther Werth (E)

Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Sleep and Health Zurich (SHZ), University of Zurich, Zurich, Switzerland.

Olivier Lambercy (O)

Rehabilitation Engineering Laboratory, ETH Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH